Search research articles
Contact Us
Filters
Showing results (81-90 of 104) with videos related to
Page
of 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study
C Jackisch, S-B Kim, V Semiglazov, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|
October 15, 2014
[Influence of preoperative chemoradiotherapy on changes of epidermal growth factor receptor expression in patients treated by preoperative chemoradiotherapy for local advanced rectal carcinoma]
I Richter, J Dvořák, A Blüml, et al.
Cancer Research
|
October 23, 1997
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro
G Ferrandina, B Melichar, A Loercher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2008
First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma
B Melichar, P Koralewski, A Ravaud, et al.
Neoplasma
|
August 5, 2020
Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer
J Gatek, V Petru, P Kosac, et al.
Neoplasma
|
July 3, 2020
Association of triple positivity with prognostic parameters and overall survival in a population-based study of 6,122 HER2-positive breast cancer patients: analysis of real-world clinical practice based on a research database
I Kolarova, J Vanasek, M Dolezel, et al.
British Journal of Cancer
|
October 27, 2011
Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
B Melichar, E Casado, J Bridgewater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2015
A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer
G Deplanque, M Demarchi, M Hebbar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma
A Ravaud, C H Barrios, B Alekseev, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|
December 11, 2014
Cancer incidence and mortality in the Czech Republic
L Dusek, J Muzik, D Maluskova, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 104) with videos related to
Sort By:
Page
of 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study
C Jackisch, S-B Kim, V Semiglazov, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|
October 15, 2014
[Influence of preoperative chemoradiotherapy on changes of epidermal growth factor receptor expression in patients treated by preoperative chemoradiotherapy for local advanced rectal carcinoma]
I Richter, J Dvořák, A Blüml, et al.
Cancer Research
|
October 23, 1997
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro
G Ferrandina, B Melichar, A Loercher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 15, 2008
First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma
B Melichar, P Koralewski, A Ravaud, et al.
Neoplasma
|
August 5, 2020
Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer
J Gatek, V Petru, P Kosac, et al.
Neoplasma
|
July 3, 2020
Association of triple positivity with prognostic parameters and overall survival in a population-based study of 6,122 HER2-positive breast cancer patients: analysis of real-world clinical practice based on a research database
I Kolarova, J Vanasek, M Dolezel, et al.
British Journal of Cancer
|
October 27, 2011
Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial
B Melichar, E Casado, J Bridgewater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2015
A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer
G Deplanque, M Demarchi, M Hebbar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 9, 2015
RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma
A Ravaud, C H Barrios, B Alekseev, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|
December 11, 2014
Cancer incidence and mortality in the Czech Republic
L Dusek, J Muzik, D Maluskova, et al.
Page
of 11